The antidepressant effects of apigenin are associated with the promotion of autophagy via the mTOR/AMPK/ULK1 pathway.


Journal

Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 06 01 2019
accepted: 06 06 2019
pubmed: 20 7 2019
medline: 14 1 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

The present study aimed to investigate whether apigenin elicits antidepressant effects in depressant‑like mice via the regulation of autophagy. The depressant‑like behaviors were established in a chronic restraint stress model. Male BALB/c mice were subjected to restraint stress for 6 h/day for a period of 21 days, and deficits in sucrose preference, tail suspension and forced swim tests were confirmed to be improved following oral apigenin. To investigate the underlining mechanisms, the hippocampal levels of p62 and microtubule‑associated protein light chain 3‑II/I (LC3‑II/I) were measured using western blot analysis. The expression levels of LC3‑II/I and p62 indicated that the significantly inhibited autophagy level induced by chronic restraint stress can be increased following apigenin treatment. Similar to the level of autophagy, the expression levels of adenosine monophosphate‑activated protein kinase (AMPK) and Unc‑51 like autophagy activating kinase‑1 were downregulated after chronic restraint stress stimulation and, subsequently upregulated following treatment with apigenin. Conversely, the levels of mammalian target of rapamycin (mTOR) were increased in chronic restraint stress mice and inhibited by apigenin. Collectively, the present findings indicated that apigenin potentially promotes autophagy via the AMPK/mTOR pathway and induces antidepressive effects in chronic restraint stress mice.

Identifiants

pubmed: 31322238
doi: 10.3892/mmr.2019.10491
doi:

Substances chimiques

Antidepressive Agents 0
Apigenin 7V515PI7F6
Protein Kinases EC 2.7.-
mTOR protein, mouse EC 2.7.1.1
Autophagy-Related Protein-1 Homolog EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Ulk1 protein, mouse EC 2.7.11.1
AMP-Activated Protein Kinase Kinases EC 2.7.11.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2867-2874

Auteurs

Xiaolong Zhang (X)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.

Hongmin Bu (H)

Lianyungang Food and Drug Inspection Center, Lianyungang, Jiangsu 222000, P.R. China.

Yan Jiang (Y)

Lianyungang Food and Drug Inspection Center, Lianyungang, Jiangsu 222000, P.R. China.

Guangda Sun (G)

Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing, Jiangsu 210023, P.R. China.

Ruizhi Jiang (R)

Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing, Jiangsu 210023, P.R. China.

Xiaoyan Huang (X)

Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing, Jiangsu 210023, P.R. China.

Huifang Duan (H)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.

Zhiheng Huang (Z)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.

Qinan Wu (Q)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH